All News

San Francisco--Stem cell therapy can repair the tissue damage that causes urinary incontinence, say Austrian researchers, who used myoblasts and fibroblasts to strengthen patients' rhabdosphincters and urethras and eliminate their symptoms.

Tracing technology can identify the precise location of the phone line your laptop is connected to.

Do you think the three available phosphodiesterase type-5 inhibitors-vardenafil hydrochloride (Levitra), tadalafil (Cialis), and sildenafil citrate (Viagra)-are essentially the same, or do they have distinct advantages in the treatment of ED?

The key advantage of the new markers is their ability to identify patients with low-grade 'nuisance' tumors.

GAO cites flaws in Medicare's policy for paying assistants-at-surgery, drawing ire of ACS and others.

Cancer is present in 15% of men with 'normal' PSAs and DREs; 2% have high-grade disease

Panel also suggests appropriate roles for combination therapy and SWL monotherapy

Studies show improved survival, longer time to progression with docetaxel-based therapy

Under our tax laws, the cost of land is a capital expense for which no tax deduction can be taken.

Stone burden significantly impacts procedure's stone-free rates and operative times.

Women given investigational agent show dry, improved outcomes more often than controls

In older patients, antidiuretic drug reduces nocturnal voiding by more than 50%

Alpha-blocker, PDE-5 combo doesn't lead to CV events

San Francisco--A commonly prescribed antibiotic and alpha-blocker appear to be ineffective in the treatment of men with moderate to severe chronic prostatitis/chronic pelvic pain syndrome of long duration. Results of a multicenter study found that both ciprofloxacin and tamsulosin-used primarily in the treatment of urinary tract infections and BPH, respectively-offered no significant benefit in the treatment of chronic prostatitis in patients who were heavily pretreated and had long-standing symptoms.

Sequential monotherapy yields poor results in CPPS

The Centers for Medicare & Medicaid Services and the National Cancer Institute have developed a joint Memorandum of Understanding to address how the two agencies can work together in five areas of technology, science, and patient care for cancer.

Four leading prostate cancer advocacy groups are working in cooperation with the FDA to streamline the approval process of critical prostate cancer treatments by changing clinical trial endpoints, without compromising safety.

The FDA issued an approvable letter for a sustained-release formulation of doxazosin mesylate (Cardura XL), an alpha-blocker used to treat BPH.

Prostate cancer patients who receive radiotherapy within 6 months of surgery live longer than those who do not receive radiotherapy, according to an Italian study appearing in the Journal of Radiation Oncology, Biology, and Physics (2004; 59:674-83).

Flexibility, negotiation, and goodwill can keep on-call tensions to aminimum

La Jolla, CA--Analysis of data from a prospective, population-based study shows common risk factors for coronary heart disease (CHD) in mid-life men significantly predict erectile dysfunction 25 years later.

Often tell staffers how they're performing, and listen to their job-related concerns

AUA guideline warns of conflicts of interest influencing PDE-5 comparison trials

Settlements create monetary funds, prevent companies from engaging in harmful practices

Sexual dysfunction and BPH appear to be strongly associated in older men, according to two new studies.

Regardless of whether it is given adjuvantly or as salvage therapy, radiation therapy reduces the likelihood of prostate cancer recurrence, according to a study in the International Journal of Radiation Oncology, Biology, Physics (2004; 59: 329-40).

Trospium chloride (Sanctura) has been approved by the FDA for the treatment of overactive bladder with symptoms of urge incontinence, urgency, and urinary frequency.

Men who have a low PSA level according to standard PSA testing can still have prostate cancer, according to a recent study in the New England Journal of Medicine (2004; 350:2239-46).